Bevacizumab-Induced Nasal Septum Perforation
Author:
Affiliation:
1. a Division of Medical Oncology, Department of Medicine, Buffalo, New York, USA
2. b Department of Pharmacy, Roswell Park Cancer Institute, Buffalo, New York, USA
Publisher
Oxford University Press (OUP)
Subject
Cancer Research,Oncology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1634/theoncologist.11-1-85
Reference5 articles.
1. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo;Kim;Nature,1993
2. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer;Hurwitz;N Engl J Med,2004
3. High-dose bevacizumab improves survival when combined with FOLFOX4 in previously treated advanced colorectal cancer: results from the Eastern Cooperative Oncology Group (ECOG) study E3200;Giantonio;Proc Am Soc Clin Oncol,2005
4. Wound healing/bleeding in metastatic colorectal cancer patients who undergo surgery during treatment with bevacizumab;Hurwitz;J Clin Oncol,2004
5. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis;Hicklin;J Clin Oncol,2005
Cited by 43 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Perforation of the Nasal Septum in a Colorectal Cancer Patient Treated With Aflibercept: A Case Report;Cureus;2022-07-12
2. A case of nasal septal perforation caused by bevacizumab for advanced cervical cancer;Journal of Obstetrics and Gynaecology Research;2020-12-09
3. Spontaneous nasal perforation in a bevacizumab-treated patient with metastatic breast cancer;The Breast Journal;2017-08-27
4. Effect of Bevacizumab Nasal Spray on Epistaxis Duration in Hereditary Hemorrhagic Telangectasia;JAMA;2016-09-06
5. Bevacizumab;Meyler's Side Effects of Drugs;2016
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3